Table 4.

Immunologic and virologic parameters in LTNPs who lost anti-CCR5 Abs during the study period

Subject code and sample date	CD4 count, cells/μL	HIV-RNA, copies/mL	Therapy	CCR5 Abs
173
Oct 95	533	184	No	Pos
Sep 03	429	483 000	Yes	Neg
Oct 04	305	330 000	Yes	Neg
167
Jan 99	443	10 800	No	Pos
Nov 03	511	12 960	No	Neg
Apr 04	331	7 000	No	Neg
131
Oct 00	656	17 000	No	Pos
Jul 02	964	82 000	No	Pos
Nov 04	905	< 50	Yes	Neg
39
Jan 02	551	94 000	No	Pos
Jan 04	369	127 658	No	Neg
Dec 04	664	71	Yes	Neg
110
Feb 96	625	14 000	No	Pos
Feb 02	577	46 000	Yes	Neg
Oct 04	238	199 603	Yes	Neg
4
Sep 95	454	13 550	No	Pos
Sep 96	326	233 063	Yes	Neg
Jun 04	525	< 50	Yes	Neg
22
May 95	728	400	No	Pos
Apr 96	579	1 102	No	Pos
Jun 97	604	7 800	Yes	Neg
11
Apr 96	464	4 900	No	Pos
Apr 98	806	39 000	Yes	Neg
May 99	873	33 000	Yes	Neg
21
Jan 95	638	2 218	No	Pos
Sep 96	468	1 827	No	Pos
Nov 97	417	15 000	Yes	Neg